Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1990 1
1991 1
1992 1
1993 2
1994 3
1996 5
1997 2
1998 3
1999 8
2000 6
2001 9
2002 3
2003 7
2004 6
2005 3
2006 3
2007 5
2008 4
2009 7
2010 3
2011 4
2012 6
2013 7
2014 2
2015 2
2016 1
2021 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.
Gozgit JM, Vasbinder MM, Abo RP, Kunii K, Kuplast-Barr KG, Gui B, Lu AZ, Molina JR, Minissale E, Swinger KK, Wigle TJ, Blackwell DJ, Majer CR, Ren Y, Niepel M, Varsamis ZA, Nayak SP, Bamberg E, Mo JR, Church WD, Mady ASA, Song J, Utley L, Rao PE, Mitchison TJ, Kuntz KW, Richon VM, Keilhack H. Gozgit JM, et al. Among authors: richon vm. Cancer Cell. 2021 Sep 13;39(9):1214-1226.e10. doi: 10.1016/j.ccell.2021.06.018. Epub 2021 Jul 22. Cancer Cell. 2021. PMID: 34375612 Free article.
Histone deacetylases.
Marks PA, Miller T, Richon VM. Marks PA, et al. Among authors: richon vm. Curr Opin Pharmacol. 2003 Aug;3(4):344-51. doi: 10.1016/s1471-4892(03)00084-5. Curr Opin Pharmacol. 2003. PMID: 12901942 Review.
Histone deacetylase inhibitors.
Marks PA, Richon VM, Miller T, Kelly WK. Marks PA, et al. Among authors: richon vm. Adv Cancer Res. 2004;91:137-68. doi: 10.1016/S0065-230X(04)91004-4. Adv Cancer Res. 2004. PMID: 15327890 Review.
Vorinostat in solid and hematologic malignancies.
Siegel D, Hussein M, Belani C, Robert F, Galanis E, Richon VM, Garcia-Vargas J, Sanz-Rodriguez C, Rizvi S. Siegel D, et al. Among authors: richon vm. J Hematol Oncol. 2009 Jul 27;2:31. doi: 10.1186/1756-8722-2-31. J Hematol Oncol. 2009. PMID: 19635146 Free PMC article. Review.
Histone deacetylases and cancer: causes and therapies.
Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Marks P, et al. Among authors: richon vm. Nat Rev Cancer. 2001 Dec;1(3):194-202. doi: 10.1038/35106079. Nat Rev Cancer. 2001. PMID: 11902574 Review.
Histone deacetylase inhibitors as new cancer drugs.
Marks PA, Richon VM, Breslow R, Rifkind RA. Marks PA, et al. Among authors: richon vm. Curr Opin Oncol. 2001 Nov;13(6):477-83. doi: 10.1097/00001622-200111000-00010. Curr Opin Oncol. 2001. PMID: 11673688 Review.
104 results